Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
31.9M
-
Shares change
-
+1.86M
-
Total reported value, excl. options
-
$1.97B
-
Value change
-
+$94.6M
-
Put/Call ratio
-
0.85
-
Number of buys
-
86
-
Number of sells
-
-99
-
Price
-
$61.68
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2023
259 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2023.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.9M shares
of 48.9M outstanding shares and own 65.15% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.78M shares), VANGUARD GROUP INC (3.49M shares), BlackRock Inc. (2.47M shares), BVF INC/IL (2.13M shares), Fairmount Funds Management LLC (2.01M shares), FMR LLC (1.36M shares), Point72 Asset Management, L.P. (1.17M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.05M shares), MILLENNIUM MANAGEMENT LLC (1.04M shares), and STATE STREET CORP (796K shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.